ESC Congress 2016

27 - 31 August 2016, Rome - Italy

Session Details

Stem cells and cell therapy
Mon 29 Aug 16:30 - 18:00 Stem cells and cell therapy Rapid Fire Abstract Agora 2 - Poster Area
Chairpersons: Rosalinda MADONNA (Chieti, Italy), Philippe MENASCHE (Paris, France)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
16:304287Susceptibility to induced ventricular tachycardias increases with time after transplantation of induced pluripotent stem cell-derived cardiomyocytes into infarcted mouse heartsGabriel PEINKOFER (Koeln, Germany)
16:394288Flecainide suppresses an arrhythmogenic substrate in Andersen-Tawil syndrome-induced pluripotent stem cell-derived cardiomyocytesYusuke KURODA (Shizuoka City, Japan)
16:484289Atrial & ventricular cardiac progenitor cells from the same heart show differential characteristics for cardiac regeneration but are superior to the endothelial progenitor cells from the same patientParul DIXIT (Dunedin, New Zealand)
16:574290Transplantation of adipose mesenchymal cells overexpressing telomerase and myocardin preserved cardiac function and promoted tissue repair in murine myocardial infarctionRosalinda MADONNA (Chieti, Italy)
17:064291The heart has a constant and significant cardiomyocyte replacement rate by endogenous cardiac stem cells in the adult lifeEleonora CIANFLONE (Catanzaro, Italy)
17:154292c-kit/CreERT2 knock-in allele does not efficiently fate-track c-kit positive resident cardiac stem cells and impairs their regenerative potentialIolanda AQUILA (Catanzaro, Italy)
17:244293Selective loss of adult cardiomyocytes is replenished by new endogenous cardiomyocyte formation in the presence of a patent coronary circulationFabiola MARINO (Catanzaro, Italy)
17:334294Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up.Domenico D'AMARIO (Rome, Italy)
17:424295A patient-specific iPS model for Holt-Oram Syndrome reveals TBX5-dependent dysregulation of down-stream targetsHarald LAHM (Munich, Germany)
17:514296Mesenchymal stem cells grown under chronic hypoxia traffic to regions of myocardial infarction, suppress splenic natural killer cells, and attenuate adverse remodeling in mice with large acute MIMichael LIPINSKI (Arlington, United States of America)